Emulate Inc. (Boston, Mass.) raised $28 million in a series B round. The company plans to expand its Organ-Chip portfolio and commercialize its Human Emulation System. New investors included OS Fund, Atel Ventures, and the...

Armed with $12 million in series A cash, Emulate Inc. is developing organs-on-chips to more rapidly and reliably predict human response to medicine than traditional animal models. Last week, Emulate spun out of the Wyss...

The Wyss Institute for Biologically Inspired Engineering at Harvard University spun out its organs-on-chips technology into newco Emulate Inc. (Cambridge, Mass.), which raised $12 million in a series A round led by NanoDimension. Cedars-Sinai Medical...

Campus Biotech said the sale of the former headquarters of Merck's Merck Serono S.A. biotech division in Geneva to the consortium behind the Campus Biotech initiative has been finalized. Hansjorg Wyss, the founder of Synthes...

A pair of billionaires made an undisclosed bid to purchase the former headquarters of Merck's Merck Serono biotech division in Geneva. Hansjorg Wyss, the founder of Synthes Inc., and Ernesto Bertarelli, the former CEO of...

A pair of billionaires made an undisclosed bid to purchase the former headquarters of the Merck Serono biotech division of Merck KGaA (Xetra:MRK) in Geneva, Switzerland. Hansjorg Wyss, the founder of Synthes Inc., and Ernesto...